Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

468
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
468
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

527
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
527
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

806
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
806
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.3K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

899
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
899
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

917
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
917

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Conserved T cell receptor usage underpins recognition of CD1c presenting a mycobacterial lipid.

bioRxiv : the preprint server for biology·2026
Same author

Controlled human infection with Mycobacterium tuberculosis: practical considerations for clinical trials.

The Lancet. Microbe·2026
Same author

BCG vaccination induces antibacterial effector functions among Vδ1/3 T cells that are associated with protection against tuberculosis.

Cell reports. Medicine·2026
Same author

IFN-γ- GranzymeB + Natural killer cells are induced by IV BCG vaccination and associated with protection against tuberculosis in rhesus macaques.

Mucosal immunology·2025
Same author

Infant CD4 T-Cell Response to SARS-CoV-2 mRNA Vaccination Is Restricted in Cytokine Production and Modified by Vaccine Manufacturer.

Open forum infectious diseases·2025
Same author

Infant CD4 T-cell response to SARS-CoV-2 mRNA vaccination is restricted in cytokine production and modified by vaccine manufacturer.

bioRxiv : the preprint server for biology·2025

関連する実験動画

Updated: Jan 10, 2026

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.9K

結核ワクチンの開発に対する体系的なアプローチ

Chetan Seshadri1

  • 1Department of Medicine, University of Washington School of Medicine, Seattle, WA 98109, USA.

Cell
|November 27, 2025
PubMed
まとめ

新しい三価 mRNA ワクチンは 結核 (TB) に対して 有望な効果を示しています この新しいワクチンはマウスに持続的な保護を提供し,既存のBCGワクチンの有効性を高めます.

科学分野:

  • 免疫学
  • ワクチン学
  • 感染症

背景:

  • 結核 (TB) は,世界的に大きな健康上の脅威であり,世界的に大きな死亡率を引き起こしています.
  • 現在のバチルス・カルメッテ・ゲーリン (BCG) ワクチンは,結核に対する様々な保護を提供している.
  • より効果的な結核ワクチンは緊急に必要である.

研究 の 目的:

  • 改善された結核ワクチンのための新しい抗原を特定する.
  • TBに対する新しい三価mRNAワクチンの開発と評価
  • BCGと併用したワクチンの有効性を評価する.

主な方法:

  • Mycobacterium tuberculosisの42の候補抗原を体系的に評価した.
  • 三価mRNAワクチンの開発
  • 結核の複数のマウスモデルでワクチンの有効性を試験する
  • mRNAワクチンによる保護とBCGとの相乗効果の評価

主要な成果:

  • 開発された三価mRNAワクチンは,マウスモデルで結核に対する有効かつ持続的な保護を示した.
  • mRNAワクチンはBCGワクチンの保護免疫を大幅に強化しました.

さらに関連する動画

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.5K
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.2K

関連する実験動画

Last Updated: Jan 10, 2026

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.9K
Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.5K
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.2K
  • 特定の抗原は,免疫の保護におけるその役割について特定され,検証された.
  • 結論:

    • 新しい三価mRNAワクチンは結核予防の有望な戦略です
    • 新型mRNAワクチンとBCGの併用療法により,より優れた予防効果が得られます.
    • このmRNAワクチンのさらなる開発は,世界的な結核の流行を制御する可能性を秘めています.